MAPK3 and malignant colon neoplasm: In summary, our results demonstrated that 5-FU treatment promotes the degradation of TMPO through autolysosome-related pathway and subsequent activation of c-Fos through ERK1/2 in colon cancer cells, which disclosed a tight negative correlation between TMPO expression and c-Fos activation.